INMUNE BIO INC (INMB:NASDAQ)
$1.94 0.15 (8.3799%)
Analysed INMUNE BIO INC (INMB:NASDAQ) News Sources
INmune Bio (INMB) Q1 2026 Earnings Transcript
08-05-2026
fool.com
INmune Bio Named Founding Member of the American Biotech Innovation Alliance (ABIA) as U.S. Biotech Sector Navigates Strategic Inflection Point
13-05-2026
yahoo.com
INmune Bio Receives FDA Fast Track Designation for XPro1595 in Early Alzheimer's Disease
14-05-2026
yahoo.com
INmune Bio Publishes Phase 2 MINDFuL Trial Results in NPJ Dementia, Advancing the XPro™ Platform
15-05-2026
yahoo.com
INmune Bio (INMB) Q4 2025 Earnings Transcript
01-06-2026
fool.com
INmune Bio Reports Statistically Significant Treatment Effect on Advanced White Matter MRI Biomarker in Phase 2 MINDFuL Alzheimer's Trial
02-06-2026
yahoo.com
INmune Bio Receives MHRA Written Alignment Supporting Planned 2026 UK Conditional Marketing Authorization Application for CORDStrom™ in RDEB
23-06-2026
yahoo.com
INmune Bio Inc. Achieves MHRA Approval of PIP for CORDStrom™
25-06-2026
yahoo.com
INmune Bio Advances CORDStrom™ Platform Patent Application in the U.S. Following Favorable International Written Opinion
01-07-2026
yahoo.com
INmune Bio to Present Positive Phase 2 Imaging Data for XPro in Early Alzheimer’s Disease at AAIC
09-07-2026
yahoo.com
What is the current price of INMUNE BIO INC (INMB:NASDAQ)?
The current price of INMUNE BIO INC (INMB:NASDAQ) is $1.94.
INMUNE BIO INC (INMB:NASDAQ) absolute price change since previous trading day?
The absolute price change of INMUNE BIO INC (INMB:NASDAQ) since the previous trading day is $0.15.
INMUNE BIO INC (INMB:NASDAQ) percentage price change since previous trading day?
The percentage price change of INMUNE BIO INC (INMB:NASDAQ) since the previous trading day is 8.3799%.
What is the most recent average sentiment score for INMUNE BIO INC (INMB:NASDAQ)?
The most recent average sentiment score for INMUNE BIO INC (INMB:NASDAQ) is 68 out of 100.
What is the most recent average sentiment for INMUNE BIO INC (INMB:NASDAQ)?
The most recent sentiment for INMUNE BIO INC (INMB:NASDAQ) is .
SEC-8K** Filing Available For INMUNE BIO INC (INMB:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.